Co-Diagnostics, Inc. 10-Q

Item 5. Other Information None. 26 Item 6. Exhibits Exhibit Index (a) Exhibits Exhibit Exhibit Description Filed Herewith Incorporated by Reference herein from Form or Schedule Filing Date SEC File/Reg. Number 4.1 Form of Indenture S-3 (Exhibit 4.1) 05/12/26 333-295803 4.2 Form of Pre-Funded Warrant Form 8-K (Exhibit 4.1) 05/21/26 001-38148 4.3 Form of Common Warrant Form 8-K (Exhibit 4.2) 05/21/26 001-38148 10.1* Form of Securities Purchase Agreement Form 8-K (Exhibit 10.1) 05/21/26 001-38148 10.2 Form of Registration Rights Agreement Form 8-K (Exhibit 10.2) 05/21/26 001-38148 10.3 Form of Placement Agency Agreement Form 8-K (Exhibit 10.3) 05/21/26 001-38148 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101.INS Inline XBRL Instance Document X 101.SCH Inline XBRL Taxonomy Extension Schema Document X 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) * *Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission. 27 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CO-DIAGNOSTICS, INC. Date: August 13, 2026 By: /s/ Dwight H. Egan Name: Dwight H. Egan Title: Chief Executive Officer and Principal Executive Officer Date: August 13, 2026 By: /s/ Brian Brown Name: Brian Brown Title: Chief Financial Officer and Principal Financial and Accounting Officer 28